Delivery Order SPE2DB22D3011-SPE2DB25FQ0MC

Award Date 4/21/25
Potential Completion Date 4/22/25
Potential Value $22K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,050.18 firm fixed-price delivery order is for the supply of 100-count capsules of 200 mg Progesterone, a hormone treatment medication. The contract has an ultimate completion date of April 22, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,611,389 units of 200 mg progesterone capsules in 100-count bottles, with a ceiling value of $6,899.45. The contract has an ultimate completion date of March 19, 2025 and was awarded on March 18, 2025. It is a firm fixed-price delivery order contract with no set-aside designation,...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,000.87 firm fixed-price delivery order is for the supply of 4,567,796,172 capsules of 200 mg progesterone. The contract has an ultimate completion date of April 4, 2025 and does not utilize any set-aside designations. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,127.74, is for the delivery of Progesterone 100 mg capsules in packs of 30 to support federal healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $27,481.35, is for the delivery of 4,568,036,318 units of the prescription medication Progesterone 200 mg capsules. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 28, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp, a for-profit...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $21,249.50, is for the delivery of 4,567,254,676 units of Progesterone 200 mg capsules. The contract has a completion date of February 13, 2025 and is a firm fixed-price delivery order. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Progesterone 100 mg capsules, valued at $13,434.45. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,068.23 firm-fixed-price delivery order is for the supply of 100 units of 200 mg progesterone capsules. The contract has an ultimate completion date of October 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $7,432.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567717293 - Progesterone 100 mg Capsule 100s. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 28, 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,738.21 contract is for the delivery of 4,567,941,083 units of the prescription medication Progesterone 200 mg capsules. The contract is a firm fixed-price, non-set-aside award with a performance period through April 17, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB25FQ0MC
    Delivery Order

This federal contract award, valued at $21,679.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100-count bottles of 200mg progesterone capsules, a hormone treatment medication.

The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) vehicle, designated as SPE2DX, which provides a comprehensive global pharmaceutical support program for the DLA, Defense Health Agency, U.S. Coast Guard, and other government agencies. AmerisourceBergen holds this $999,999,999.00 IDC, allowing the company to supply a wide range of pharmaceutical products and medical supplies to support federal healthcare programs, particularly for military and veteran services.

The awarded contract has a firm fixed-price pricing type and an ultimate completion date of April 22, 2025. It does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor, AmerisourceBergen is well-positioned to fulfill the federal government's diverse medical supply requirements through its extensive portfolio of brand-name and generic medications across multiple therapeutic areas.

Generated 7/21/25, 7:42 PM